These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33913064)

  • 41. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).
    Cha DS; Carmona NE; Mansur RB; Lee Y; Park HJ; Rodrigues NB; Subramaniapillai M; Rosenblat JD; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Shekotikhina M; Zhou AJ; Rong C; Harrison J; McIntyre RS
    Scand J Pain; 2017 Apr; 15():62-67. PubMed ID: 28850348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder.
    McIntyre RS; Xiao HX; Syeda K; Vinberg M; Carvalho AF; Mansur RB; Maruschak N; Cha DS
    CNS Drugs; 2015 Jul; 29(7):577-89. PubMed ID: 26290264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder.
    Lee RS; Hermens DF; Porter MA; Redoblado-Hodge MA
    J Affect Disord; 2012 Oct; 140(2):113-24. PubMed ID: 22088608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computerised cognitive training in Parkinson's disease: a protocol for a systematic review and updated meta-analysis.
    Gavelin HM; Domellöf M; Leung I; Neely AS; Finke C; Lampit A
    BMJ Open; 2020 Nov; 10(11):e040656. PubMed ID: 33234647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal course of cognitive function across treatment in patients with MDD: A meta-analysis.
    Bernhardt M; Klauke S; Schröder A
    J Affect Disord; 2019 Apr; 249():52-62. PubMed ID: 30753954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Computerized cognitive training in people with depression: a protocol for a systematic review and meta-analysis.
    Lampit A; Launder NH; Minkov R; Rollini A; Davey CG; Finke C; Lautenschlager NT; Gavelin HM
    Syst Rev; 2022 Jan; 11(1):6. PubMed ID: 34991698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
    Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
    J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.
    Rodgers M; Asaria M; Walker S; McMillan D; Lucock M; Harden M; Palmer S; Eastwood A
    Health Technol Assess; 2012 May; 16(28):1-130. PubMed ID: 22642789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
    Levada OA; Troyan AS
    J Affect Disord; 2019 May; 250():114-122. PubMed ID: 30852363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: A systematic review.
    Cambridge OR; Knight MJ; Mills N; Baune BT
    Psychiatry Res; 2018 Nov; 269():157-171. PubMed ID: 30149273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive dysfunction in major depressive disorder.
    Knight MJ; Baune BT
    Curr Opin Psychiatry; 2018 Jan; 31(1):26-31. PubMed ID: 29076892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review.
    Evans VC; Iverson GL; Yatham LN; Lam RW
    J Clin Psychiatry; 2014 Dec; 75(12):1359-70. PubMed ID: 25551235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of cognitive impairment in psychosocial functioning in remitted depression.
    Knight MJ; Air T; Baune BT
    J Affect Disord; 2018 Aug; 235():129-134. PubMed ID: 29655074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Huperzine A for treatment of cognitive impairment in major depressive disorder: a systematic review of randomized controlled trials.
    Zheng W; Xiang YQ; Ungvari GS; Chiu FK; H Ng C; Wang Y; Xiang YT
    Shanghai Arch Psychiatry; 2016 Apr; 28(2):64-71. PubMed ID: 27605862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Addressing cognitive impairment following stroke: systematic review and meta-analysis of non-randomised controlled studies of psychological interventions.
    Merriman NA; Sexton E; McCabe G; Walsh ME; Rohde D; Gorman A; Jeffares I; Donnelly NA; Pender N; Williams DJ; Horgan F; Doyle F; Wren MA; Bennett KE; Hickey A
    BMJ Open; 2019 Feb; 9(2):e024429. PubMed ID: 30819706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Falls in older adults with major depressive disorder (MDD): a systematic review and exploratory meta-analysis of prospective studies.
    Stubbs B; Stubbs J; Gnanaraj SD; Soundy A
    Int Psychogeriatr; 2016 Jan; 28(1):23-9. PubMed ID: 26234532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.
    Maneeton N; Maneeton B; Srisurapanont M; Martin SD
    BMC Psychiatry; 2012 Sep; 12():160. PubMed ID: 23017200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.